Clinical Research Policies

Cancer or Cancer-Related studies policy requiring scientific review or monitoring  (PDF)

Effective January 2, 2006: All human subject cancer or cancer-related protocols (therapeutic/treatment, prevention, ancillary/companion and correlative), must be reviewed, approved, and monitored by the Kansas Masonic Cancer Research Institute's Protocol Review and Monitoring Committee (PRMC).

PRMC approval must be obtained prior to the Principal Investigator beginning the submission process to the Human Subjects Committee (HSC). Monitoring of the ongoing research will take place after all compliance approvals have been completed.